TABLE 2.
Variable | SARS‐CoV‐2 (n = 28) | Control (n = 16) | P‐value |
---|---|---|---|
Unadjusted | 0.185 | ||
HRR1min | −22 ± 10 | −29 ± 10 | 0.024* |
HRR2min | −28 ± 12 | −36 ± 11 | 0.024* |
HRR3min | −30 ± 13 | −39 ± 13 | 0.043* |
HRR4min | −31 ± 14 | −42 ± 12 | 0.019* |
HRR5min | −31 ± 14 | −43 ± 13 | 0.012* |
Adjusted for %Pred 6MWT distance | 0.202 | ||
HRR1min | −22 ± 9 | −28 ± 9 | 0.029* |
HRR2min | −28 ± 10 | −35 ± 10 | 0.027* |
HRR3min | −31 ± 11 | −37 ± 11 | 0.056 |
HRR4min | −32 ± 12 | −41 ± 12 | 0.024* |
HRR5min | −32 ± 12 | −42 ± 12 | 0.013* |
Adjusted for resting HR | 0.228 | ||
HRR1min | −22 ± 9 | −28 ± 9 | 0.031* |
HRR2min | −28 ± 11 | −36 ± 11 | 0.033* |
HRR3min | −30 ± 13 | −38 ± 13 | 0.063 |
HRR4min | −32 ± 13 | −41 ± 13 | 0.028* |
HRR5min | −32 ± 13 | −42 ± 13 | 0.018* |
Adjusted for BMI | 0.206 | ||
HRR1min | −22 ± 10 | −29 ± 10 | 0.027* |
HRR2min | −28 ± 11 | −36 ± 11 | 0.027* |
HRR3min | −30 ± 13 | −38 ± 13 | 0.050* |
HRR4min | −31 ± 14 | −42 ± 14 | 0.023* |
HRR5min | −32 ± 14 | −42 ± 14 | 0.014* |
Adjusted for age | 0.224 | ||
HRR1min | −22 ± 10 | −29 ± 10 | 0.032* |
HRR2min | −28 ± 12 | −36 ± 12 | 0.035* |
HRR3min | −30 ± 13 | −38 ± 14 | 0.054 |
HRR4min | −31 ± 14 | −41 ± 14 | 0.026* |
HRR5min | −32 ± 14 | −42 ± 14 | 0.017* |
Abbreviations: BMI, body mass index; HR, heart rate; HRR1min, HRR2min, etc., the difference in HR immediately post‐6MWT compared with each minute of recovery; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; 6MWT, 6‐minute walk test; %Pred 6MWT distance, distance travelled during the 6MWT normalized to a reference sample using predictive equations provided by Casanova et al. (2011). Note. The P‐value shown in bold is the omnibus test statistic for MANOVA/MANCOVA.
P ≤ 0.05 between SARS‐CoV‐2 and control groups.